Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.7.11.12 (
PKG
)
2,515
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
cGMP-dependent protein kinase
-I (cGK-I) induces apoptosis in various cancer cell lines. However, the signaling mechanisms involved remain unknown. Using protein microarray technology, we identified a novel cGK substrate,
death-associated protein kinase 2
(
DAPK2
), which is a Ca(2+)/calmodulin-regulated serine/threonine kinase. cGK-I phosphorylated
DAPK2
at Ser(299), Ser(367) and Ser(368). Interestingly, a phospho-mimic mutant,
DAPK2
S299D, significantly enhanced its kinase activity in the absence of Ca(2+)/calmodulin, while a S367D/S368D mutant did not. Overexpression of
DAPK2
S299D also resulted in a twofold increase in apoptosis of human breast cancer MCF-7 cells as compared with wild-type
DAPK2
. These results suggest that
DAPK2
is one of the targets of cGK-I in apoptosis induction.
...
PMID:cGMP-dependent protein kinase I promotes cell apoptosis through hyperactivation of death-associated protein kinase 2. 2258 Feb 83